Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03252470
Other study ID # 2015-SE-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 6, 2018
Est. completion date March 20, 2019

Study information

Verified date August 2019
Source Olympus Corporation of the Americas
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a hypothesis generating pilot study to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox platform, during laparoscopic bariatric surgery.


Description:

Data published in 2008 estimated the global number of surgical procedures performed annually as 234 million with a rate of major perioperative complications reported between 3% and 17% in industrialized countries. As a derivative of these figures, it is estimated that approximately 7 to 40 million major complications occur worldwide each year. Studies have shown that between 39.6% and 54.2% of surgical complications occur in the operating room (OR); furthermore, it has been suggested that one third to half of all surgical errors are potentially avoidable. These findings have brought considerable attention to quality improvement in the technically demanding field of laparoscopic surgery wherein the risk of intraoperative error is increased by the sociotechnical complexity of the operative environment. In particular, there has been growing interest in evaluating surgical processes from a human factors point of view, as human factors, such as fatigue and mental workload, have become increasingly recognized as root causes of adverse surgical events and outcomes.

Among the most commonly reported errors in conventional laparoscopic surgery are technical errors associated with impaired depth perception; laparoscopic surgeons rely on two-dimensional (2D) video displays to guide their work in a three-dimensional (3D) space, resulting in the loss of depth perception and spatial orientation, as well as the experience of increased visual and cognitive load. Technical errors can be defined as manual errors of the surgeon (e.g. damage to adjacent structures) and procedural errors due to a lack of surgeon proficiency or experience. These errors are frequently described, especially when evaluating closed malpractice cases. These factors have been extensively examined but still remain controversial. A major limitation of error analyses of closed malpractice cases and root cause analyses of complications is the hindsight bias introduced through the knowledge of patient outcome.

Laparoscopic cameras with 3D display functionality were first developed in the early 1990s. The poor image quality produced by early cameras resulted in pronounced physical side effects, including dizziness, headache, and nausea; however, a significant technological advancement in the field of 3D laparoscopy has dramatically improved the usability of these systems. Despite these improvements and the potential for improved surgical safety, the use of 3D laparoscopic equipment remains limited in modern surgical centers. Outdated and conflicting research findings regarding the effectiveness of these systems and the physical side effects associated with their use may be contributing to slow adoption into clinical practice. Furthermore, investigations assessing the impact of 3D laparoscopy on surgical performance in the clinical setting are notably lacking. Thus, robust comparative evaluations of modern 2D and 3D laparoscopic surgical display systems in clinical settings are required to clearly elucidate the impact of 3D laparoscopy on surgical performance and safety with an aim to establish best practices in laparoscopic surgery.

The restoration of stereoscopic vision in laparoscopic surgery has the potential to mitigate these challenges and, to this end, the introduction of 3D stereoscopic displays in laparoscopic surgery may be beneficial to improving surgical safety. The purpose of this study is to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox Platform, during laparoscopic Roux-en-Y gastric bypass surgery.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 20, 2019
Est. primary completion date March 11, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. = 18 years of age

2. Scheduled to undergo elective, primary roux-en-y gastric bypass surgery

3. BMI of 35 to 54.9

4. Willing and able to provide informed consent

Exclusion Criteria:

1. Previous open abdominal surgery

2. Previous open or laparoscopic upper GI surgery

3. Contraindicated for laparoscopic bariatric surgery

4. Unable or unwilling to provide informed consent

Study Design


Related Conditions & MeSH terms

  • Laparoscopic Roux-en-y Gastric Bypass

Intervention

Procedure:
Laparoscopic Roux-en-y Gastric Bypass Surgery
Laparoscopic Roux-en-y Gastric Bypass Surgery

Locations

Country Name City State
Canada St. Michael's Hospital, Division of Surgery Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Olympus Corporation of the Americas St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantify operative performance and intraoperative errors This pilot study will quantify operative performance and intraoperative errors after the introduction of the 2D and 3D technology using the following tools:
Generic Error Rating Tool (GERT)
Objective Structured Assessment of Technical Skill (OSATS)
12 months
Secondary Significant adverse events 1. Clinically significant adverse events related to the device(s) and/or procedure one month
See also
  Status Clinical Trial Phase
Withdrawn NCT02008409 - Evaluation of Safety and Efficacy of the EndoLift Liver Retractor N/A